New Pancreatic Cancer Treatment Proves Effective in Shrinking ...

Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic ...

Pancreatic Cancer Tumors in Mice Shrink after Nano Delivery of ...

The combination treatment approach resulted in long-term survival in relevant mouse models of pancreatic ductal adenocarcinoma (PDAC). Reporting ...

Pancreatic Cancer News - ScienceDaily

Aug. 26, 2024 — Researchers discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy more effective. Folinic acid elevates ...

Chemo Boosts KRAS Inhibitor Against Pancreatic Cancer - NCI

A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse: chemotherapy. Two new studies ...

A Rare Story of Hope in Pancreatic Cancer Treatment

Jeff's tumor started shrinking within eight weeks of starting the therapy. A year later, the tumor had shrunk by 53%, with no new growths ...

Moe Abdo, MD on LinkedIn: New pancreatic cancer treatment ...

Moe Abdo, MD's Post · New pancreatic cancer treatment proves effective in shrinking, clearing tumors · More Relevant Posts · Researchers develop ...

Pancreatic Tumors - latest research news and features

New pancreatic cancer treatment proves effective in shrinking, clearing tumors. Aug 28, 2024. New anti-CKAP4 antibodies deliver hope for pancreatic cancer ...

Injectable, radioactive gel synergizes with chemotherapy to shrink ...

NIBIB-funded researchers are developing a new method to treat pancreatic cancer ... demonstrates such a robust response in multiple and ...

Breakthroughs in Pancreatic Cancer Treatment - UC Health

This approach, combining chemotherapy and/or radiation therapy before surgery, is designed to shrink pancreatic tumors, thereby increasing the ...

Novel genetic experiment shrinks tough-to-treat cancer | AP News

In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells.

University of Massachusetts Amherst | Research posted on the topic

The treatment includes two methods: preventing immune system recognition of cancer cells and boosting immune system attack potential against the ...

Current status of non-surgical treatment of locally advanced ...

These effects in combination with immunotherapy may offer a new treatment paradigm for tumors with low immunogenic potential, like pancreatic ductal ...

Novel Treatment Approaches for Pancreatic Cancer - YouTube

Navigating treatment options for pancreatic cancer is often complicated due to the complexity of the disease, different progressing stages, ...

Newfound Mechanism Suggests Drug Combination Could Starve ...

A new combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a new study finds.

Current and future immunotherapeutic approaches in pancreatic ...

Tumor immunotherapy has revolutionized the treatment of various solid tumors. Nevertheless, current immunotherapies have had limited success in ...

Reprogrammed Cells Attack and Tame Deadly Cancer in One Woman

Researchers have managed to tame pancreatic cancer in a woman whose cancer was far advanced and after other forms of treatment had failed.

New study examines if 'inoperable' pancreatic tumors can be safely ...

The study will investigate if chemotherapy followed by a novel type of surgery to remove the cancer is a safe and effective option for patients with locally ...

Total Neoadjuvant Therapy: The New Standard for Pancreatic ...

Pancreatic cancer has long been treated with surgery followed by chemotherapy or radiation. However, reversing the order of those ...

TGen-HonorHealth clinical trial shows tumor shrinkage in 71 percent ...

Extensive testing led by HonorHealth and TGen demonstrated that the combination enabled longer survival for patients with advanced pancreatic ...

Treatment Clinical Trials for Pancreatic Cancer - NCI

The addition of pembrolizumab to the usual treatment of olaparib may help to shrink tumors in patients with metastatic pancreatic cancer with BRCA1 or BRCA2 ...